In his first interview since becoming chief financial officer, Ken Lim said the embattled health giant was seeing signs of ...

CSL’s fireman tells us how he’s reviving the Australian market’s Bambi. Investors are yet to reward him for it.

Brokers remain upbeat and see upside up to 95% for the biotech stock. The post CSL shares slide again in March — but is a comeback brewing? appeared first on The Motley Fool Australia.

Business remains robust and brokers see ASX stock soaring up to 100%. The post CSL shares look primed to take off — Here's ...

This biotech giant's shares have lost half of their value. Let's see if now is the time to snap them up for the long-term. The post Are '50% off' CSL shares a once-in-a-decade opportunity? appeared ...

Brokers see significantly more upside ahead for Pro Medicus. The post Forget CSL shares, this ASX healthcare stock could ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A casual enthusiast might tell you that BMW’s M-badged models are the company’s peak performance offerings. The true fans know that in reality, the rare CSL models are a cut above. In its latest video ...

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...